Cancer Research Funding Press Releases
Washington, D.C.---Today the House Appropriations Committee will vote on a proposed FY 2022 spending bill that would increase funding for the National Institutes of Health (NIH) by $6.5 billion and include a $432 million increase for the National Cancer Institute (NCI), and $194 million for the Cancer Moonshot.
ACS CAN applauds new investment in New Jersey Commission on Cancer Research.
AUSTIN, TX – June 23, 2021 – With Gov.
The Biden administration released its budget for FY 22 late last week. Included in the budget is an additional $9 billion in funding for the National Institutes of Health (NIH), including $6.5 for the creation of a new department within the NIH called the Advanced Research Project Agency on Health (ARPA-H).
The American Cancer Society Cancer Action Network (ACS CAN) and the HL7 FHIR Accelerator™ Common Oncology Data Elements eXtensions (CodeX) are working together with partners on a project to increase and expand patient enrollment in cancer clinical trials at smaller and non-research oriented medical centers.
A new report from the American Cancer Society Cancer Action Network (ACS CAN) takes an in-depth look at disparities across all areas of cancer research and suggests immediate policy solutions that could help address such gaps in the years to come.
A group of more than fifty cancer research-focused organizations are urging Congress to include $10 billion in emergency funding to restart cancer research and clinical trials at the National Institutes of Health (NIH) stalled by the coronavirus pandemic.
ACS CAN President Lisa Lacasse reacts to President Biden's declaration we will, "End cancer as we know it." The statement was part of the president's address to a joint session of Congress.
BATON ROUGE, LA – As lawmakers dive into the new legislative session, the American Cancer Society Cancer Action Network (ACS CAN) looks ahead to what public health initiatives our lawmakers can accomplish during the 2021 legislative session.
Karen E. Knudsen, MBA, Ph.D., will be the next chief executive officer of the American Cancer Society (ACS) and its advocacy affiliate, the American Cancer Society Cancer Action Network (ACS CAN), starting June 1, 2021. She will take the reins from the retiring Gary Reedy, who has served as both organizations’ CEO since 2015.